10/27/09, (NYSE:ABT), $50.89, "SUPER BUY" ABBOTT LABORATORI (ABT) Stock on Tuesday, October 27, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     10/27/09, (NYSE:ABT), $50.89, "SUPER BUY" ABBOTT LABORATORI (ABT) Stock  ABT opened at $N/A and it is $0.00, (0.00%). Today's trading range is $N/A - N/A. 1y target price is $56.91.  DOW     -1.05%    -104.22    9867.96           ENGLAND     +0.16%    +8.16    5199.90           JAPAN     -1.45%    -150.16    10212.46  NASDAQ     Updating    Updating    2141.85           GERMANY     -0.04%    -2.46    5639.70           CHINA     -2.83%    -88.11    3021.459  S&P 500     Updating    Updating    1066.95           FRANCE     -0.03%    -1.2    3743.25           INDIA     -1.38%    -231.47    16509.029  CANADA     Updating    Updating    11234.88           ITALY     -1.09%    -174.00    15743.00           RUSSIA     -1.65%    -24.38    1451.68  MEXICO     -1.10%    -337.6    30280.080           SWISS     -0.03%    -2.01    6301.34           TAIWAN     -0.14%    -11.06    7657.34

Stocks Funds SYMBOL:    YouTube Our Blog 10/17/09 StockRing Urgent Advice: Sell stocks on 10/19/09 - expect pull back this week !!!    Option Exp: SAMPLE ! Option Exp: Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on 10/26/2009:  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on 10/26/2009:  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/26/2009:  Buy   71% or 141   Hold   11% or 23   Sell   18% or 35 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   3% or 1025   Sell   18% or 508 stocks Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings 10/27/2009  Tuesday, October 27, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for ABBOTT LABORATORI (NYSE:ABT) Stock. ABT stock opening price was $50.77 per share. Current price of NYSE:ABT Stock is $50.89 per share and it is $0.00, (0.00%) today and it was trading in the daily range of $50.73 - 51 per share. Current Bid Price for (NYSE:ABT) stock is $0.00 and the Ask Price is $0.00. In the last 52 weeks ABT stock was trading in the range of $41.27 - 57.40. 50-Day Moving Average for (NYSE:ABT) stock is $48.9514 and 200-Day Moving Average is $45.8727. On average analysts predict that One Year Target Estimated price for (NYSE:ABT) stock is $56.91. ABBOTT LABORATORI (NYSE:ABT) Market capitalization is $78.671B. (NYSE:ABT) stock average daily volume is 8,539,280 shares per day. However, on last trading session of Oct 26, 2009 ABT stock traded shares. Also The Short Ratio for (NYSE:ABT) stock is 1.20. On previous trading session ABT Stock closed at $50.89 per share. Last year ABBOTT LABORATORI (NYSE:ABT) before taxes (EBITDA) (ttm) earned $8.640B on total revenue of $29.926B. Earnings Per Share - EPS (ttm) for ABT stock is 3.693. Also, (NYSE:ABT) Stock Price Per Earnings ratio - P/E is 13.78. Thus, (NYSE:ABT) Stock Price/Sales (ttm) ratio is 2.63 and Price/Book (mrq) ratio is 3.96. (NYSE:ABT) Stock pays a dividend of $1.56 per share which is a yield of 3.07%. So at this time (NYSE:ABT) Stock maintains Trailing Annual Dividend Rate at 1.56 . StockRing Recommendations for ABBOTT LABORATORI (NYSE:ABT) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=ABT If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. ABT Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/27/2009 1 Year Stock market price chart for ABBOTT LABORATORI (NYSE:ABT) Stock on Tuesday, October 27, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 10/27/2009 5 days Stock market price chart for ABBOTT LABORATORI (NYSE:ABT) Stock on Tuesday, October 27, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart ABT Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/27/2009 Stock market price quote data for ABBOTT LABORATORI (NYSE:ABT) Stock on Tuesday, October 27, 2009 Last Trade: 50.89 Trade Time: Oct 26 Change: 0.00, (0.00%) Prev Close: 50.89 Open: 50.77 Bid: 0.00 Ask: 0.00 1y Target Est: $56.91 50-Day Moving Average: 48.9514 200-Day Moving Average: 45.8727 Short Ratio: 1.20 Trailing Annual Dividend Rate: 1.56 Day's Range: 50.73 - 51 52wk Range: 41.27 - 57.40 Volume: Avg Vol: 8,539,280 Market Cap: 78.671B P/E (ttm): 13.78 EPS (ttm): 3.693 Div & Yield: 1.56 (3.07%) Revenue (ttm): 29.926B Earnings before Tax (EBITDA) (ttm): 8.640B Price/Sales (ttm): 2.63 Price/Book (mrq): 3.96 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on 10/26/2009:  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on 10/26/2009:  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/26/2009:  Buy   71% or 141   Hold   11% or 23   Sell   18% or 35 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   3% or 1025   Sell   18% or 508 stocks 10/27/2009 Latest stock market news data for ABBOTT LABORATORI (NYSE:ABT) Stock on Tuesday, October 27, 2009 EU Committee To Size Up Abbott, Solvay Cholesterol Drugs EasyBourse.com - 12 hours ago By Peter Loftus A European regulatory body plans to examine whether certain cholesterol drugs have long-term clinical benefits--and one potential outcome could be their withdrawal from the market ... BioCurex Poised For Positive Future Based On Results (OTC:BOCX) istockAnalyst.com - 15 hours ago BioCurex Inc (Public, OTC:BOCX) http://www.biocurex.com/ BioCurex, Inc. ("BioCurex" or "the Company") is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that ... Abbott Laboratories (ABT) Trading In Tight Support/Resistance Range Market Intelligence Center - 19 hours ago Abbott Laboratories (NYSE: ABT) ended the last trading session at $51.31. So far the stock has hit a 52-week low of $41.27 and 52-week high of $57.40. Abbott Laboratories stock has been showing ... Abbott Opens New R&D Center at University of Illinois Research Park Reuters - Oct 22, 2009 CHAMPAIGN, Ill., Oct. 22 /PRNewswire-FirstCall/ -- Abbott, a global health care company today celebrated the dedication of its new Abbott Nutrition facility at the Research Park on the University ... Baxter and Abbott Refuse to Be Toppled by Foreign Currency Headwinds, an Industrial Info News Alert PR-CANADA.net - Oct 22, 2009 Researched by Industrial Info Resources (Sugar Land, Texas) -- Global pharmaceutical companies Baxter International Incorporated (NYSE:BAX) (Deerfield, Illinois) and Abbott Laboratories (NYSE:ABT ... MZ Announces Agreement with Sodali for 2010 IR Global Rankings Reuters - Oct 21, 2009 NEW YORK, Oct. 21 /PRNewswire/ -- MZ Consult NY LLC ("MZ"), a leading investor relations, technology, financial services and integrated communications consulting firm and coordinator of IR Global ... SNAP Diagnostics is First Diagnostics Company to Join SAFE-BioPharma Association Reuters - Oct 21, 2009 FT. LEE, NJ--(Business Wire)-- SNAP Diagnostics,a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE ... Abbott Completes Visiogen Acquisition Reuters - Oct 20, 2009 ABBOTT PARK, Ill., Oct. 20 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced that it has completed its acquisition of privately held eye care company Visiogen, expanding the company's ... Abbott Buys Visiogen For $400 Million - Trading Markets Abbott acquires Visiogen; expands vision care business - News-Medical.net AZoOptics.com Abbott Laboratories Completes Visiogen Acquisition Reuters Key Development - Oct 20, 2009 Stock Picks: LXK Up, BSX Down Smartmoney.com - Oct 20, 2009 Shares of Lexmark International (LXK) toned up Tuesday after the printer maker posted better than expected results and outlook. Shares were up 14% in midday trading after the Lexington, Ky ... Abbott Laboratories: Dividend Stock Analysis Seeking Alpha (blog) ABT is trading at a discount to 1.) and 3.) above. The stock is trading at a 21.9% premium to its calculated fair value of $42.18. ABT did not earn any ... Abbott Labs 3Q Net Up 36%, Boost '09 Earns View Wall Street Journal Abbott Laboratories (ABT) reported a 36% increase in third-quarter profit, helped by higher sales of nutritional ... Abbott Labs Q3 Profit Surges 16% on Strong Humira Sales (ABT)Dividend.com (blog) Consistency Makes This Stock a WinnerMotley Fool Abbott Earnings Rise More Than Expected on HumiraBloomberg BloggingStocks (blog) -Seeking Alpha (blog) -The Associated Press all 383 news articles » Voice of America Stock Market Update Briefing.com Abbott Labs (ABT) complemented the reports by offering up better-than-expected earnings of its own. Meanwhile, the dollar's drop to fresh 52-week lows has ... About this author:Seeking Alpha (blog) US Market Wrap - 15/10/09, 8.12am ESTFinance News Network Two Reasons the Dow's Rally to 10000 Will Keep Moving Aheaddodjit.com Briefing.com all 2,502 news articles » Stock Picks: LXK Up, BSX Down Smartmoney.com ... combined with pricing weakness in its drug-coated stents and a profit-sharing deal with Abbot Laboratories (ABT), prompted a more moderate view, ... and more » Last Week to Register for the 2010 IR Global Rankings Reuters ... among them (in alphabetical order): A8 Digital Music Holdings (HKSE: 0800); Abbott (NYSE: ABT); ABNote (BMF&BOVESPA: ABNB3); Acer Inc. (TWSE: 2353); ... and more » Abbott Laboratories (ABT) Bullish Technical Alert - Trend Up 14.2% Trading Markets (press release) The stock has traded within a 52-week range of $41.27 and $57.40. Abbott Laboratories is currently above its 50-day moving average of $47.15 and above its ... Core Laboratories Up 26% Since SmarTrend's Buy RecommendationTrading Markets (press release) all 4 news articles » Weekly Roundup TheStreet.com (subscription) Abbott Laboratories (ABT: NYSE, $51.31, 2100 shares, 3.64%) INDUSTRY SECTOR - HEALTHCARE: Shares continue to work higher as investors appreciate the ... and more » Boston Globe The Heart Company's Disheartening Forecast Motley Fool David Gardner's top stock jumps 1334%! See what David recommends that you buy NEXT. The medical-devices business continues moving erratically in an ... CORRECT (10/19): Boston Scientific Swings To 3Q ProfitWall Street Journal Boston Scientific cuts profit outlook, shares slideTehran Times all 393 news articles » Pre-Market Stock Upgrades/Downgrades Oct 20, 2009 Wall Street Pit (blog) Abbott Labs announces (NYSE:ABT) the FDA has granted 510(k) clearance for an antibody cyclic-citrulinated peptide, or anti-CCP assay, to run on the world ... and more » HULIQ Deal Stocks: BAC, AIG, JPM, ABT, CBS, VIA, RA The Daily Deal Abbott Laboratories (NYSE:ABT) reported third-quarter earnings per share of 92 cents beating analyst estimates by 2 cents. It was a less-than-stellar debut ... Wall Street Jumps On Upbeat Earnings, Wells Fargo (NYSE: WFC) SurgesistockAnalyst.com (press release) Deal Stocks: C, BCS, JPM, BAC, WFC, BXThe Daily Deal all 31 news articles » 10/27/2009 News from StockRing Blog about ABBOTT LABORATORI (NYSE:ABT) Stock on Tuesday, October 27, 2009    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA